Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04333810 · ClinicalTrials.gov registry record

Remote Physiologic Monitoring to Detect Inflammatory Bowel Disease (IBD) Flares: A Feasibility Study

A clinical trial, sponsored by Milton S. Hershey Medical Center.

Completed
Registry status
8
Enrollment target

NCT04333810 is a clinical trial that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 8 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04333810 has completed, sponsored by Milton S. Hershey Medical Center.

COMPLETED
Registry status
8 participants
Enrollment target

Study Summary

Inflammatory bowel disease (IBD) has become a more prominent disease in the US population, with more than 3 million adults in the US affected. To manage this disease effectively, physicians tend to need to have a multidisciplinary approach as there are many psychosocial implications of chronic gastrointestinal illnesses like Crohn's and Ulcerative Colitis. Recent literature has supported the desire for telemedicine and remote physiologic monitoring for such patients to allow the patient to be more active in their treatments and make physicians more aware of what their bodies are doing from a physiologic perspective. Whoop is a new device founded in 2011 that has grown in popularity for its ability to accurately measure sleep patterns, resting heart rate, and heart rate variability (HRV) amongst other various physiologic measurements. Newer literature supports that depressed heart rate variability can correlate to disease flares such as heart failure exacerbations. The study investigators proposed that using remote physiologic monitoring in the IBD population along with their symptoms can help predict disease severity and potentially lead to earlier interventions if correlations are accurate. It can also spark interest in the younger generation for remote physiologic monitoring and telemedicine, which is believed to be beneficial in patients with chronic illnesses.

Interventions

  • DEVICE Whoop strap 3.0

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2020-10-01
Est. Completion 2023-07-31

Sponsor

Milton S. Hershey Medical Center

396 total trials

What the Registry Record Tells You About NCT04333810

The ClinicalTrials.gov registry entry for NCT04333810 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Whoop strap 3.0 is the first listed.

NCT04333810 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04333810 about?

NCT04333810 is a clinical study titled "Remote Physiologic Monitoring to Detect Inflammatory Bowel Disease (IBD) Flares: A Feasibility Study". Inflammatory bowel disease (IBD) has become a more prominent disease in the US population, with more than 3 million adults in the US affected. To manage this disease effectively, physicians tend to need to have a multidisciplinary approach as there are many psychosocial implications of chronic gastr...

What is the current status of trial NCT04333810?

This trial is currently completed. The enrollment target is 8 participants. The study started on 2020-10-01. Estimated completion is 2023-07-31.

What interventions are being tested in trial NCT04333810?

The interventions under investigation include: Whoop strap 3.0 (DEVICE).

Who is sponsoring clinical trial NCT04333810?

This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.